俯卧位对COVID-19 ARDS患者通气-血流匹配的时间依赖性效应:电阻抗成像评估
本研究为前瞻性生理学研究的事后分析,纳入18例接受机械通气的COVID-19相关ARDS患者,在首次俯卧位期间五个时间点(俯卧位前仰卧位SP、俯卧位1小时PP1、3小时PP3、16小时PPend、转回仰卧位3小时RE-SP3)用电阻抗成像评估区域通气-血流匹配。结果显示俯卧位使PaO2/FiO2持续升高并在PPend达峰,背侧通气在PP1即显著增加(P=.047)并持续上升,背侧血流在前3小时不变、至PPend显著增加;正常V/Q比例升高,无灌注、低V/Q比例下降,尤其在背侧区域。转回仰卧位后通气与血流回到基线,无通气、低V/Q、无灌注比例较俯卧位时明显升高。
要点
- 18例COVID-19 ARDS机械通气患者首次俯卧位,PaO2/FiO2在各俯卧位时间点持续升高,于俯卧位16小时(PPend)达峰。
- 背侧通气在俯卧位1小时即显著增加(P=.047),并持续上升,PPend较PP1升高更明显(P<.001)。
- 背侧血流在俯卧位前3小时不变,至PPend才显著增加;通气与血流在转回仰卧位3小时(RE-SP3)回到基线。
- 俯卧位增加正常V/Q比例、降低无灌注与低V/Q比例,以背侧区域为主;转回仰卧位后无通气、低V/Q、无灌注比例较俯卧位时明显升高。
- 整体不均匀性(GI)-V/Q比值在俯卧位期间下降,并与PaO2/FiO2升高相关。
适用人群与场景
- COVID-19相关ARDS、接受机械通气并接受首次俯卧位治疗的患者(本研究纳入18例)。
处置流程与药物剂量
- 首次俯卧位 session 中于五个时间点行PaO2/FiO2测量与电阻抗成像评估:俯卧位前仰卧位(SP)、俯卧位1小时(PP1)、3小时(PP3)、16小时(PPend)、转回仰卧位3小时(RE-SP3)。
研究设计与关键结果
- 研究类型:前瞻性生理学研究的事后分析;样本量18例COVID-19 ARDS机械通气患者,均接受首次俯卧位治疗。
- 与SP相比,俯卧位使氧合显著改善,PaO2/FiO2在各俯卧位时间点持续升高,于PPend达峰。
- 背侧通气在PP1显著增加(P=.047),俯卧位期间稳步上升,PPend较PP1升高更明显(P<.001)。
- 背侧血流在俯卧位前3小时保持不变,至PPend显著增加。
- 通气与血流在RE-SP3回到基线水平。
- 与SP相比,俯卧位增加正常V/Q(%)、降低无灌注(%)与低V/Q(%),尤其在背侧肺区域。
- 与俯卧位相比,RE-SP3时无通气(%)、低V/Q(%)、无灌注(%)明显升高。
- 整体不均匀性(GI)-V/Q比值在俯卧位期间下降,并与PaO2/FiO2升高相关。
证据类型、等级与局限
- 证据类型:前瞻性生理学研究的事后分析(sub-analysis)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论:在COVID-19诱导的ARDS患者中,俯卧位初期通过改善通气分布、降低低V/Q(%)来改善氧合与V/Q匹配;随时间推移血流变化进一步改善V/Q匹配,但患者转回仰卧位后这些获益消失,导致V/Q失匹配加重。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Prone positioning (PP) has been shown to improve oxygenation in patients with acute respiratory distress syndrome (ARDS); with a focus on its early physiological effects. However, the time-dependent effects of PP on ventilation-perfusion (V/Q) matching have not been fully investigated. In this study we aimed to investigate the longitudinal effects of PP on regional V/Q matching and the distribution of ventilation and perfusion in patients with coronavirus disease 2019 (COVID-19)-associated ARDS.
METHODS: This study analyzed patients with COVID-19 ARDS who were mechanically ventilated and underwent their first PP treatment. V/Q mismatching was assessed using electrical impedance tomography (EIT). At five intervals during the initial PP session PaO2/FiO2 measurements and EIT evaluations were performed including: before the initiation of PP while in the supine position (SP), 1 h after PP (PP1), 3 h after PP (PP3), 16 h after PP (PPend), and 3 h after reverting to the supine position (RE-SP3).
RESULTS: In this study eighteen COVID-19 ARDS patients were enrolled. In comparison with SP, PP led to significant improvements in oxygenation, with PaO2/FiO2 consistently increasing at each PP time point and peaking at PPend. Dorsal ventilation significantly increased at PP1 (P = .047), and steadily rose during PP, with a higher increase at PPend than PP1 (P < .001). Dorsal perfusion remained unchanged during the first three hours of PP; however, significantly increased by PPend. Ventilation and perfusion returned to their baseline levels at RE-SP3. PP increased normal V/Q (%), and decreased non-perfused (%), low V/Q (%), particularly in the dorsal lung regions, compared with SP. At RE-SP3, there was a marked increase in the non-ventilated (%), low V/Q (%), and non-perfused (%) compared with PP. The global inhomogeneity (GI)-V/Q ratio was noted to have decreased during PP and correlated with an increase in PaO2/FiO2.
CONCLUSIONS: In COVID-19-induced ARDS patients, prone positioning initially improves oxygenation and V/Q matching by enhancing ventilation distribution and decreasing low V/Q (%). Over time, perfusion changes further improve V/Q matching, but these benefits diminish once the patient returns to the supine position, leading to increased V/Q mismatch. Trial registration Clinical Trials.gov, NCT04725227. Registered 25 January 2021, https://clinicaltrials.gov/study/NCT04725227?cond=NCT04725227&rank=1.
参考来源
- Wang Y, Muhetaer Y, Zheng X, et al. Time-dependent effects of prone position on ventilation-perfusion matching assessed by electrical impedance tomography in patients with COVID-19 ARDS: sub-analysis of a prospective physiological study. Ann Intensive Care. 2025. PMID: 40163279. doi:10.1186/s13613-025-01452-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。